CJ Beneduce

CJ brings over 9 years of experience in numerous aspects of drug development, spanning from target identification and validation, competitive analysis, antibody discovery, lead optimization, and translational development. Prior to joining FASI, CJ was a scientist at Momenta Pharmaceuticals (now part of Johnson & Johnson), where he supported multiple projects across the immunology portfolio. Within this sector, his projects included early research, portfolio programs, and novel target identification at both the technical and operational level.

CJ earned his Bachelor of Science Degree in chemistry from Northeastern University.  CJ previous work has focused on developing deeper understanding of how glycosylation impacts the function of antibodies in addition to expanding our understanding of stromal-immune interactions in the context of autoimmunity.